Influence of histamine and serotonin antagonists on the growth of xenografted human colorectal tumors.
Four lines of human colorectal cancer were established and serially propagated as subcutaneous xenographs in immunosuppressed inbred CBA/Lac mice. Established xenografts were then used to investigate the influence of a serotonin antagonist (BW 501c) and a histamine H2 receptor antagonists (Cimetidine) on xenograft growth. The growth of each of the four tumor lines was significantly inhibited by BW 501c throughout the treatment, whereas the growth of only two tumor lines was significantly inhibited by Cimetidine treatment. The response of individual tumor lines was not predictable on the basis of either tumor histopathology or the natural growth rate of the untreated xenograft. A number of alternative, but not mutually exclusive, hypotheses are suggested to explain the results. One hypothesis proposes that colorectal tumors are composed of subpopulations of tumor cells that are variously dependent on or independent of amine hormones. Another hypothesis is that tumor cells exhibit temporal changes in hormone sensitivity to amine hormones during treatment. Finally, it is suggested that serotonin and/or histamine H2 antagonists may be useful in preventing the repopulation of colorectal carcinomas following antineoplastic therapy with the use of conventional drugs.
D000578:Amidines / Q000494:pharmacology; D000818:Animals; D002927:Cimetidine / Q000494:pharmacology*; D003110:Colonic Neoplasms / Q000473:pathology / Q000503:physiopathology*; D005260:Female; D006146:Guanidines / Q000494:pharmacology*; D006801:Humans; D007700:Kinetics; D008297:Male; D051379:Mice; D008808:Mice, Inbred CBA; D009368:Neoplasm Transplantation; D012004:Rectal Neoplasms / Q000473:pathology / Q000503:physiopathology*; D012702:Serotonin Antagonists / Q000494:pharmacology*; D014183:Transplantation, Heterologous
D000578:Amidines; D006146:Guanidines; D012702:Serotonin Antagonists; C029751:BW 501C; D002927:Cimetidine